KUKJEON PHARMACEUTICAL Co., Ltd (KOSDAQ:307750)
South Korea · Delayed Price · Currency is KRW 3,715.00
-105.00 (-2.75%)
At close: Apr 9, 2026
KUKJEON PHARMACEUTICAL Market Cap
KUKJEON PHARMACEUTICAL has a market cap or net worth of 199.54 billion as of April 10, 2026. Its market cap has increased by 21.57% in one year.
Market Cap
199.54B
Enterprise Value
214.45B
Revenue
131.04B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,715.00
Market Cap Chart
Since December 16, 2020, KUKJEON PHARMACEUTICAL's market cap has increased from 37.63B to 199.54B, an increase of 430.33%. That is a compound annual growth rate of 36.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 201.68B | 19.45% |
| Dec 30, 2025 | 168.84B | -2.11% |
| Dec 30, 2024 | 172.48B | -43.67% |
| Dec 28, 2023 | 306.19B | -5.74% |
| Dec 29, 2022 | 324.84B | -39.54% |
| Dec 30, 2021 | 537.31B | 40.12% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| RS Automation | 201.59B |
| AXBIS | 201.14B |
| VenueG | 201.00B |
| DASAN Networks | 200.57B |
| SKAI worldwide | 200.17B |
| MAKUS | 199.87B |
| ABION | 199.57B |
| UBcare. | 198.15B |